Transcode Therapeutics RNAZ
NASDAQ RNAZ
$1.77 +0.05 (+3.21%)
At close: Oct 23, 2026 · 4:00 PM EDT

Transcode Therapeutics (RNAZ) Cash & Current Investments (2020 - 2026)

Updated

Transcode Therapeutics' Cash & Current Investments was $8.4 million in Q2 2026, up 13.5% from $7.4 million a year earlier but down 34.6% from the prior quarter.

Analysis

Transcode Therapeutics (RNAZ) Cash & Current Investments (2020 - 2026) Analysis & Trends

At the end of FY2025, Cash & Current Investments at Transcode Therapeutics came in at $17.81 million, up 206.5% from FY2024.

  • Cash & Current Investments shows a five-year compound annual growth rate of 84.7% (FY2020 to FY2025).
  • In earlier years, Cash & Current Investments was $5.81 million in FY2024 (+110.0%), $2.77 million in FY2023 (-44.3%), $4.97 million in FY2022 (-76.1%) and $20.83 million in FY2021.
  • Quarterly Cash & Current Investments has moved between $1.62 million (Q1 2023) and $22.5 million (Q3 2021) over five years.
  • Compared with a year earlier, Cash & Current Investments has increased for seven straight quarters, with growth averaging 71.1% over the last eight quarters.
  • The best year-over-year quarter for Cash & Current Investments over five years was Q4 2025 (growth of 206.5%); the worst was Q1 2023 (a decline of 90.4%).
  • Per Business Quant data, RNAZ's Cash & Current Investments in the three quarters before Q2 2026 was $12.84 million (Q1 2026), $17.81 million (Q4 2025) and $2.84 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Eli Lilly 1,137.66 Bn 1,106.24 Bn 19.71 Bn 8.95 Bn
2 Johnson & Johnson 636.13 Bn 556.00 Bn 17.30 Bn 17.23 Bn
3 AbbVie 505.28 Bn 478.39 Bn 12.70 Bn 6.57 Bn
4 Merck 358.10 Bn 312.48 Bn 12.21 Bn 7.14 Bn
5 Novartis Ag 292.59 Bn 256.58 Bn 11.24 Bn 7.69 Bn
6 Astrazeneca 265.81 Bn 239.50 Bn 12.86 Bn 4.90 Bn
7 Amgen 237.53 Bn 192.93 Bn 7.24 Bn 13.99 Bn
8 Gilead Sciences 194.67 Bn 168.86 Bn 6.22 Bn 3.18 Bn
9 Pfizer 171.17 Bn 117.82 Bn 10.94 Bn 11.70 Bn
10 Transcode Therapeutics 1.69 Mn -40.20 Mn - 8.40 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 8.40 Mn
Mar 31, 2026 12.84 Mn
Dec 31, 2025 17.81 Mn
Sep 30, 2025 2.84 Mn
Jun 30, 2025 7.40 Mn
Mar 31, 2025 11.60 Mn
Dec 31, 2024 5.81 Mn
Sep 30, 2024 1.90 Mn
Jun 30, 2024 3.40 Mn
Mar 31, 2024 4.91 Mn
Dec 31, 2023 2.77 Mn
Sep 30, 2023 7.50 Mn
Jun 30, 2023 3.60 Mn
Mar 31, 2023 1.62 Mn
Dec 31, 2022 4.97 Mn
Sep 30, 2022 8.80 Mn
Jun 30, 2022 13.44 Mn
Mar 31, 2022 16.90 Mn
Dec 31, 2021 20.83 Mn
Sep 30, 2021 22.50 Mn
API Access

Transcode Therapeutics Cash & Current Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=cash-and-current-investments&ticker=RNAZ&period=max&api_key=YOUR_API_KEY